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Edited by Beat ImhofAbstract D-pinitol has been demonstrated to exert insulin-like
and anti-inﬂammatory activities. However, its anti-allergic eﬀect
in the Th1/Th2 immune response is poorly understood. Recently,
it was shown that T-bet and GATA-3 are master Th1 and Th2
regulatory transcription factors. In this study, we have attempted
to determine whether D-pinitol regulates Th1/Th2 cytokine pro-
duction, T-bet and GATA-3 gene expression in OVA-induced
asthma model mice. We also examined to ascertain whether
D-pinitol could inﬂuence eosinophil peroxidase (EPO) activity.
After being sensitized and challenged with ovalbumin (OVA)
showed typical asthmatic reactions. These reactions included
an increase in the number of eosinophils in bronchoalveolar
lavage (BAL) ﬂuid, an increase in inﬂammatory cell inﬁltration
into the lung tissue around blood vessels and airways, airway
luminal narrowing, and the development of airway hyper-respon-
siveness (AHR). The administration of D-pinitol before the last
airway OVA challenge resulted in a signiﬁcant inhibition of all
asthmatic reactions. Accordingly, this study may provide evi-
dence that D-pinitol plays a critical role in the amelioration of
the pathogenetic process of asthma in mice. These ﬁndings pro-
vide new insight into the immunopharmacological role of D-pin-
itol in terms of its eﬀects in a murine model of asthma, and also
broaden current perspectives in our understanding of the immu-
nopharmacological functions of D-pinitol.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Asthma is a chronic inﬂammatory lung disease that is char-
acterized by airway hyper-responsiveness to allergens, airway
edema, and increased mucus secretion. A propensity for aller-*Corresponding author. Fax: +82 51 243 2259.
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doi:10.1016/j.febslet.2006.11.077gic responses, atopy, is associated with the development of
asthma [1]. OVA-induced asthma is characterized by AHR
and inﬂammation of the airways [2]. This inﬂammation is asso-
ciated with the inﬁltration of eosinophils, neutrophils, and
lymphocytes into the bronchial lumen and lung tissues [2,3].
These cellular inﬁltrates release various chemical mediators
that can cause AHR [4–6]. Recruitment of these inﬂammatory
cells from the blood to the site of inﬂammation is regarded as a
critical event in the development and persistence of airway
inﬂammation. Inﬂammatory cells have to cross the basement
membrane and move through connective tissue until they ﬁnal-
ly reach inﬂammatory sites, and require the involvement of
adhesion molecules, cytokines, chemokines, and enzymes such
as matrix metalloproteinases (MMPs) in this journey. The
MMPs are a family of zinc- and calcium-dependent endopep-
tidases capable of proteolytically degrading many of the com-
ponents of the extracellular matrix [7]. MMPs are produced
not only by structural cells [8,9], but also by inﬂammatory cells
[10–13]. They are secreted in their latent forms, followed by
proteolytic processing to the active forms [7]. Of the MMP
family, MMP-2 (gelatinase A, 72-kDa gelatinase) and MMP-
9 (gelatinase B, 92-kDa gelatinase) share similar domain struc-
tures and in vitro matrix substrate speciﬁcities [14], and appear
to induce the migration of eosinophils, lymphocytes, neutro-
phils, and dendritic cells across basement membranes during
tissue injury and repair [15,16]. Recruitment of leukocytes
from the circulating blood into tissues requires a series of cell
adhesion molecules, including ICAM-1 and VCAM-1, which
are shown to play important roles in the induction of airway
inﬂammation.
The ﬂavonoids comprise a family of common phenolic plant
pigments, which have been identiﬁed as dietary anticarcino-
gens and antioxidants [17]. We reported previously that a vari-
ety of phytochemicals exhibit profound immunoregulatory
activity, particularly in DC [18–20]. D-pinitol (3-O-methyl-chi-
roinositol), an active component of the traditional antidiabetic
plant, Bougainvillea spectabilis, reportedly exerts insulin-like
eﬀects. Pinitol is also known to exert insulin-like eﬀects, via
the driving of creatine and other nutrients into muscle cells
[21]. In addition, D-pinitol has been suggested to possess mul-
tifunctional properties, including anti-inﬂammatory activityblished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic diagram of the experimental protocol. Mice were
immunized intraperitoneally (i.p.) with 20 lg of OVA emulsiﬁed in
1 mg of aluminum hydroxide on day 1 and 15. Mice were challenged
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vascular diseases [23].
In conclusion, it has been shown using animal models that
allergic airway inﬂammation is impaired by Th2 cytokine pro-
duction and decreased Th1 cytokine production. In a recent
study, it was suggested that T-bet might protect against
asthma through increased expression of GATA-3 mRNA in
asthmatic airways [24–26]. This study investigated the role of
D-pinitol on T-bet and GATA-3 in a murine model of asthma.for 30 min via the airway with OVA (50 mg/ml of saline) each day from
days 21 to 23 on consecutive days. D-pinitol was administered i.p. with
10 mg/kg/day, 20 mg/kg/day on days 18–20.2. Materials and methods
2.1. Animals and experimental protocol
Female BALB/c mice, 6–8 weeks of age and free of murine-speciﬁc
pathogens, were obtained from the Charles River Laboratories (Yoko-
hama, Japan). All experimental animals used in this study were main-
tained under a protocol approved by the Institutional Animal Care
and Use Committee of the Pusan National University Medical School.
Mice were immunized intraperitoneally (i.p.) with 20 lg of OVA
(Sigma–Aldrich, St. Louis, MO) emulsiﬁed in 1 mg of aluminum
hydroxide (Pierce Chemical Co., Rockford, IL) on days 1 and 15. Mice
were challenged for 30 min via the airway with OVA (50 mg/ml of sal-
ine) each day from days 21 to 23 on consecutive days. BAL ﬂuid was
obtained at 24 h after the last challenge. At the time of lavage, the mice
(six mice in each group) were killed with an overdose of ether. The
chest cavity was exposed to allow for expansion, after which the tra-
chea was carefully intubated and the catheter secured with ligatures.
Prewarmed saline solution was slowly infused into the lungs and with-
drawn. The aliquots were pooled and then kept at 4 C. A part of each
pool was then centrifuged, and the supernatants were kept at 70 C
until use (Fig. 1).2.2. Administration of D-pinitol
Mice were injected i.p. with 10 or 20 mg/kg/day in 200 ll of D-pinitol
(Sigma) each day from days 18 to 20 on consecutive days.2.3. Total cell counting
The total cell numbers were counted with a hemacytometer. Smears
of BAL cells prepared with Cytospin II (Shandon, Runcorn, UK) were
stained with Diﬀ-Quik solution (Dade Diagnostics of P.R. Inc.,
Aguada, PR) for diﬀerential cell counting. Two independent, blinded
investigators counted the cells, using a microscope. Approximately,
200 cells were counted in each of four diﬀerent random locations.2.4. T cell counting by ﬂow cytometric analysis
Equal amount of BAL ﬂuids in each group, 5 · 105 cells were incu-
bated in staining buﬀer (PBS with 2% FBS and 0.1% sodium azide)
containing FITC-conjugated anti-CD3e Ab (BD Pharmingen) for
15 min on ice to block the non-speciﬁc binding. Cells stained with
the appropriate isotype-matched Ig were used as negative controls.
After staining, the cells were ﬁxed with 4% w/v paraformaldehyde
and analyzed by FACSCalibur, using CellQuest software (BD Biosci-
ences)
T cell number ¼ BAL Fluids Total cell T cell ð%Þ
T cell ð%Þ ¼ T cell number=FACS reading cells ð104Þ  1002.5. Measurement of eosinophil peroxidase
The suspension of BAL cells and the pulmonary homogenates were
frozen/thawed three times using liquid nitrogen and a water bath at
37 C to obtain the EPO. The BAL ﬂuid was centrifuged to 4 C for
10 min and serially diluted in a 96-well plate (75 ll/well) followed by
the addition of 150 ll of substrate (1.5 mM o-phenylenediamine and
6.6 mMH2O2 in 0.05 M Tris–HCl, pH 8.0). After 30 min at room tem-
perature, the reaction was stopped by the addition of 75 ll of 30%
H2SO4, and the absorbance of the samples was determined at
492 nm on an ELISA reader.2.6. Immunohistochemistry
At 48 h after the last challenge, lungs were removed from the mice
after they had been sacriﬁed. Prior to the removal of the lungs, the
lungs and trachea were ﬁlled intratracheally with a ﬁxative (4% para-
formaldehyde) using a ligature around the trachea. Lung tissues were
ﬁxed with 10% (v/v) paraformaldehyde. The specimens were dehyd-
rated and embedded in paraﬃn. For histological examination, 4 lm
sections of ﬁxed embedded tissues were cut on a Leica model 2165
rotary microtome (Leica, Nussloch, Germany), placed on glass slides,
deparaﬃnized, and sequentially stained with hematoxylin 2 and
eosin-Y (Richard-Allan Scientiﬁc, Kalamazoo, MI). An inﬂammation
score was graded by three independent investigators who were not
associated with this study.2.7. RNA preparation and quantitative RT-PCR
The total RNA from lung tissues was isolated with the use of a rapid
extraction method (TRI-Reagent) (Invitrogen Life Technologies, CA,
USA), as previously described [14]. Real-time PCR was performed
on cDNA samples using the SYBR Green system (Bio Rad, Rich-
mond, CA). Primers used were T-bet sense 5 0-CAA CAA CCC CTT
TGC CAA AG-3 0, T-bet antisense 5 0-TCC CCC AAG CAG TTG
ACA GT-3 0; GATA-3 sense 5 0-GAG GTG GAC GTA CTT TTT
AAC ATC G-3 0, GATA-3 antisense 5 0-GGC ATA CCT GGC TCC
CGT-3 0. Cycling conditions were 1 cycle at 50 C for 2 min, 1 cycle
at 95 C for 10 min, and 40 cycles each corresponding to 15 s at
95 C and 1 min at 60 C. Analysis used the sequence detection
software supplied with the instrument. The relative quantitation value
is expressed as 2 ± DcT, where DCT is the diﬀerence between the
mean CT value of duplicates of the sample and of the GAPDH
control.2.8. Measurement of cytokines
Levels of IFN-c, IL-4, IL-5 and Eotaxin were quantiﬁed in the
supernatants of BAL ﬂuids by enzyme immunoassays performed
according to the manufacturer’s protocol of the manufacturer (IFN-
c, IL-4, IL-5, Eotaxin; R&D Systems, Inc., Minneapolis, MN).2.9. Measurement of Th1/Th2 cytokine production in BLAB/c spleen
cells
Flow cytometric analysis was performed, as described by Kim et al.
[18]. OVA-induced spleen cells were pre-treated before 2 h with D-pin-
itol 10 lg/ml, 20 lg/ml and then stimulated for 24 h with 2 lg/ml OVA
peptide (OVA 323–339). Brieﬂy, 5 · 105 cells were incubated in stain-
ing buﬀer (PBS with 2% FBS and 0.1% sodium azide) containing
anti-CD4 Ab (BD Pharmingen) for 15 min on ice to block the non-spe-
ciﬁc binding of Igs. Cells stained with the appropriate isotype-matched
Ig were used as negative controls. After staining, the cells were ﬁxed
with 4% w/v paraformaldehyde and analyzed by FACSCalibur, using
CellQuest software (BD Biosciences). For intracellular cytokine stain-
ing, the cells were treated with brefeldin A (10 lg/ml; 4 h; 37 C),
washed with 1% v/v FBS-PBS (staining buﬀer), and ﬁxed in 4% w/v
paraformaldehyde (20 min for 4 C). Subsequently, the cells were
washed twice in staining buﬀer, permeabilized in 100 ll of 0.1% sapo-
nin, 1% FBS-PBS (permeabilization buﬀer), and incubated with
PE-conjugated ani-IL-4 mAb and stained with FITC-conjugated
anti-IFN-c mAb, (30 min; 4 C). Appropriate isotype-matched, irrele-
vant mAbs served as negative controls.
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Airway responsiveness was measured in mice 24 h after the last chal-
lenge in an unrestrained conscious state, as described previously [24].
Mice were placed in a barometric plethysmographic chamber (All
Medicus Co., Seoul, Korea) and baseline readings were taken and
averaged for 3 min. Aerosolized methacholine in increasing concentra-
tions (2.5–50 mg/ml) was nebulized through an inlet of the main cham-
ber for 3 min. Readings were taken and averaged for 3 min after each
nebulization. Enhanced pause (Penh), calculated as (expiratory time/
relaxation time1) · (peak expiratory ﬂow/peak inspiratory ﬂow),
according to protocol of the manufacturers, is a dimensionless value
that represents a function of the proportion of maximal expiratory
to maximal inspiratory box pressure signals and a function of the tim-
ing of expiration. Penh was used as a measure of airway responsiveness
to methacholine. Results were expressed as the percent increase of
Penh following challenge with each concentration of methacholine,
where the baseline Penh (after saline challenge) was expressed as
100%. Penh values were averaged for 3 min after each nebulization
and evaluated.Fig. 2. Eﬀect of Curcumin on total and diﬀerential cellular compo-
nents of BAL ﬂuids of OVA-sensitized and OVA-challenged mice.
Mice were treated a with the Con (PBS), OVA plus D-pinitol 10 mg/kg/
day, 20 mg/kg/day (OVA + Pin 10, OVA + Pin 20) and OVA (OVA),
respectively, as described in Section 2. The BAL cells were collected 1
day after the OVA challenge. The diﬀerent cell types were enumerated.
The arrow is pointed at eosinophils. The results were from one
representative experiment out of 5 performed. This experiment used
ﬁve mice (n = 5). ***P < 0.001 vs. OVA, *P < 0.01 vs. OVA. NEU,
neutrophil; EOS, eosinophil; LYM, lymphocyte; MAC, macrophages;
TOT, total cell.2.11. Zymography
Gelatin zymography was used to assess the activity of MMP-9. The
supernatant was diluted three times with non-reducing loading buﬀer
(400 mmol/L Tris–HCL, 5% sodium dodecyl sulfate, 20% glycerol,
0.006% bromophenol blue). Fifteen microlitres of equal amounts of
the sample were mixed with the loading buﬀer, and proteins were sep-
arated by polyacrylamide gel electrophoresis (0.75 mm; constant cur-
rent 20 mA) consisting of an 8% sodium dodecyl sulfate solution with
1% gelatin (Bio-Rad). The gels were incubated in a renaturing buﬀer
(2.5% Triton X-100 buﬀer) for 30 min to remove the sodium dodecyl
sulfate. After rinsing, the gels were incubated (37 C for 20 h) in
an enzyme activation buﬀer (50 mmol/L Tris–HCL [pH 7.3],
200 mmol/L NaCl, and 0.02% Tween 20). The gels were then stained
with Coomassie brilliant blue R250 stain and destained (5% metha-
nol, 7% acetic acid in PBS solution), and the gelatinolytic activity
was detected as clear bands. The molecular weight of the gelatinolytic
bands was estimated relative to the prestained molecular-weight
markers (see BluePlus2 Prestained Standard; Invitrogen, Carlsbad,
CA).2.12. Densitometric analysis and statistics
Experiments were repeated at least three times with consistent re-
sults. Unless otherwise stated, data are expressed as the means ±
S.E.M. ANOVA was used to compare experimental groups to control
values while comparisons between multiple groups were performed
using Tukey’s Multiple Comparison test. Statistical signiﬁcance was
indicated by a P value less than 0.05. P*** < 0.001, P** < 0.05,
P* < 0.01.3. Results
3.1. D-pinitol decreases the increased numbers of inﬂammatory
cells in BAL ﬂuids of OVA-sensitized and OVA-challenged
mice
The total cell numbers in BAL ﬂuids were signiﬁcantly in-
creased, about 10-fold, compared to those in the control group
2 days after the last OVA challenge. The number of neutro-
phils, eosinophils, lymphocytes, and Macrophages in BAL ﬂu-
ids was increased 16-, 94-, 3-, and about 8-fold, respectively,
compared to those in the control group at 2 days after the
OVA challenge. Interestingly, the number of neutrophils,
eosinophils, lymphocytes, and monocytes observed in BAL ﬂu-
ids in the D-pinitol treated group of mice decreased to the level
of 16-, 9-, 2-, 2-fold of OVA-challenge group. The administra-
tion of the D-pinitol signiﬁcantly reduced the increase in neu-
trophils, eosinophils, lymphocytes, macrophages and total
cells elicited in the airway lumen 2 days after OVA inhalation
(Fig. 2).3.2. D-pinitol inhibits CD3e+ T cell number in BAL Fluids
Numbers of CD3e+ T cell in BAL ﬂuids were increased
signiﬁcantly at 24 h after OVA inhalation (24.27%) compared
with the numbers after saline inhalation (6.04%) (Fig. 3,
Table 1). The increased numbers of CD3e+ T cell were signif-
icantly reduced by the administration of D-pinitol (19.32%).
3.3. Eﬀect of D-pinitol on changes in eosinophils in BAL ﬂuids
The levels of eosinophils in BAL ﬂuids were signiﬁcantly in-
creased at 24 h after OVA inhalation compared with the levels
after saline inhalation (Fig. 4). The increased levels of these
cells were signiﬁcantly reduced by about 53% (Pin 10 mg)
and 71% (Pin 20 mg) upon administration of D-pinitol.
3.4. D-pinitol turns on pathological changes of OVA-induced
asthma
Histological analyses revealed typical pathologic features of
asthma in the OVA-exposed mice, as compared with the con-
trol, with the OVA-exposed mice showing numerous inﬂam-
matory cells, including eosinophils inﬁltrated around the
bronchioles (Fig. 5). Mice treated with D-pinitol showed
marked reductions in the inﬁltration of inﬂammatory cells in
the peribronchiolar and perivascular regions (Fig. 5). The in-
creased total lung inﬂammation and cell inﬁltration were sig-
niﬁcantly reduced by the administration of D-pinitol. These
results suggest that D-pinitol inhibits antigen-induced inﬂam-
mation in the lungs, including the inﬂux of eosinophils.
3.5. Eﬀect of D-pinitol on expression of MMP-9 mRNA, T-bet
and GATA3 mRNA levels in lung tissues of OVA-sensitized
and -challenged mice
Quantitative RT-PCR analysis revealed that expression of
MMP-9 and GATA3 mRNA in lung tissues was signiﬁcantly
increased at 24 h after OVA inhalation compared with the
Fig. 3. D-pinitol decreased CD3e+ T cell levels in BAL ﬂuids of OVA-
sensitized and OVA-challenged mice. The cells were harvested and
analyzed via two-color ﬂow cytometry. Sampling was performed at
72 h after the last challenge in saline-inhaled mice administered saline
(Con), OVA-sensitized mice administered saline (OVA), and OVA-
sensitized mice administered Pin 10 mg/kg/day (OVA + Pin 10) and
Pin 20 mg/kg/day (OVA + Pin 20). The BAL ﬂuids were stained PE-
conjugated anti-CD3 mAb. The Dot plots shown are gated on BAL
cells. Data represent means ± S.E.M. from three independent experi-
ments.
Fig. 4. Eosinophil peroxidase (EPO) activity in BAL ﬂuids of OVA-
sensitized and -challenged mice. EPO is an indicator of the numbers of
eosinophil levels. The increased levels of EPO were signiﬁcantly
reduced about 53% (OVA + Pin 10 mg/kg/day), 71% (OVA + Pin
20 mg/kg/day) compared with OVA-treated mice. The results were
from one representative experiment out of 5 performed. This exper-
iment used ﬁve mice (n = 5). ***P < 0.001.
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mRNA expression of MMP-9, GATA-3 was decreased by
the administration of D-pinitol. Conversily, D-pinitol treated
group increase T-bet mRNA in Th1 transcription factor T-
bet (Fig. 6A).
3.6. D-pinitol regulates on levels of IL-4, IL-5, Eotaxin and IFN-
c in lung tissues of OVA-sensitized and -challenged mice
BAL ﬂuids were obtained 4 h after the last airway challenge.
The levels of IL-4, IL-5 and Eotaxin in the BAL ﬂuids wereTable 1
D-pinitol inhibits CD3e+ T cell numbers in BAL Fluids
% CD3e+ Positive cell
Group CON OVA
Percentage of total 6.04 % 24.27 %
T cell number 3 · 105 cells 1.25 · 106 cells
D-pinitol decreased CD3e+ T cell levels in BAL ﬂuids of OVA-sensitized and
color ﬂow cytometry. Sampling was performed at 72 h after the last challenge
administered saline (OVA), and OVA-sensitized mice administered Pin 10 m
BAL ﬂuids were stained PE-conjugated anti-CD3e mAb. The Dot plots show
independent experiments. Total cells were 5 · 106 cells in each group.signiﬁcantly increased by airway challenge with OVA when
compared with that of the control. The administration of D-
pinitol reduced the concentration of IL-4, IL-5, and Eotaxin
secretion (Fig. 7A, C, D). As shown in Fig. 5, the levels of
Th2 cytokines, IL-4 and IL-5, were found to be increased in
OVA-sensitized and -challenged mice, but that of the Th1
cytokine, IFN-c (Fig. 7B) was signiﬁcantly decreased as com-
pared to saline-sensitized and -challenged mice. These results
indicate that D-pinitol treatment not only selectively inhibits
Th2 cytokine levels but also increases Th1 cytokine in the
BAL ﬂuids.
3.7. Eﬀect of D-pinitol on Th1/Th2 cytokine production in CD4+
T cells
The levels of IL-4-positive CD4+ T cell in the spleen cells
were signiﬁcantly increased by stimulating with OVA (37.7%)
when compared with that of the control (5.76%) (Fig. 8). Fol-
lowing D-pinitol 10, 20 lg/ml treatment, there was increased in
the number of IFN-c positive CD4+ T cell (43.1%) when com-
pared with that of the OVA stimulating group (17.69%).
3.8. Eﬀect of D-pinitol on airway hyper-responsiveness
Airway responsiveness was assessed as the percent increase
of Penh in response to increasing doses of methacholine. In
OVA-sensitized and -challenged mice, the dose–response curve
of percent Penh was shifted to the left compared with that ofOVA + Pin 10 mg/kg/day OVA + Pin 20 mg/kg/day
21.67 % 19.32 %
1.1 · 106 cells 9.5 · 105 cells
OVA-challenged mice. The cells were harvested and analyzed via two-
in saline-inhaled mice administered saline (Con), OVA-sensitized mice
g/kg/day (OVA + Pin 10) and Pin 20 mg/kg/day (OVA + Pin 20). The
n are gated on BAL cells. Data represent means ± S.E.M. from three
Fig. 5. D-pinitol inhibits lung inﬂammation and inﬂammatory cells inﬁltration. Mice were sensitized and challenged as described in Section 2.
Sections were obtained from the lungs of mice receiving the control (CON), OVA plus D-pinitol (OVA + Pin 10 mg/kg/day, 20 mg/kg/day) and OVA
(OVA). Lungs were removed 2 days after the last airway challenge. Sections were stained by haematoxylin and eosin staining (200·).
Fig. 6. Eﬀect of D-pinitol on MMP-9, T-bet, GATA3 and GAPDH mRNA expression in lung tissues of OVA-sensitized and -challenged mice.
Sampling was performed at 24 h after the last challenge in saline-inhaled mice administered saline (CON), OVA-inhaled mice administered saline
(OVA), OVA-inhaled mice administered D-pinitol 10 mg/kg/day (OVA + Pin 10) and OVA inhaled mice administered D-pinitol 20 mg/kg/day
(OVA + Pin 20).
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Fig. 7. Eﬀect of D-pinitol treatment on Th1, Th2 cytokine. OVA-sensitized mice were treated as described in Fig. 1. (A) BAL ﬂuid was performed 4 h
after the last airway challenge as described by the manufacturer. Eotaxin levels in the BAL ﬂuids were measured by ELISA Kit. Saline-inhaled mice
administered saline (CON), OVA-inhaled mice administered saline (OVA), OVA-inhaled mice administered D-pinitol 10 mg/kg/day (OVA + Pin 10)
and OVA inhaled mice administered D-pinitol 20 mg/kg/day (OVA + Pin 20). (B) The mice were bled 4 h after the last airway OVA challenge. The
detection limit of the IFN-c assay was 5 pg/ml, and the assay is assured by the manufacturer to be speciﬁc for the IFN-c ELISA kit. (C) BAL ﬂuid
was performed 4 h after the last airway challenge as described by the manufacturer. IL-4 cytokine levels in the BAL ﬂuids were measured by ELISA
Kit. (D) BAL ﬂuid was performed 4 h after the last airway challenge as described by the manufacturer. IL-5 cytokine levels in the BAL ﬂuids were
measured by ELISA Kit. Data represent means ± S.E.M. from ﬁve independent experiments of the response in 4–8 animals. ***P < 0.001.
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by methacholine administration (at doses from 2.5 mg/ml to
50 mg/ml) increased signiﬁcantly in the OVA-sensitized and
-challenged mice compared with the controls. OVA-sensitized
and -challenged mice treated with D-pinitol showed a dose–re-
sponse curve of percent Penh that shifted to the right
compared with that of untreated mice. The shift was dose-
dependent. These results indicate that D-pinitol treatment
reduces OVA-induced airway hyper-responsiveness.
3.9. D-pinitol inhibited on MMP-9 gelatinolytic activity
OVA-challenge induced a marked induction of matrix
metalloproteinase-9 activity in BAL ﬂuids in comparison to
control mice (Fig. 10). When the administration D-pinitol
10 mg/kg/day, this increased MMP-9 gelatinolytic activity
was signiﬁcantly inhibited (Fig. 10). These results indicate that
D-pinitol regulates MMP-9 gelatinolytic activity in lung tis-
sues.4. Discussion
This study is the ﬁrst to provide experimental evidence dem-
onstrating that D-pinitol inhibits OVA-induced airway inﬂam-
mation in a murine model of asthma. D-pinitol profoundly
inhibited asthmatic reactions such as leukocytic recruitment
into the airway and lung inﬂammation. We also demonstrated
that D-pinitol regulates the Th1/Th2 balance, which can be
mediated by the level of T-bet and GATA3 levels.OVA-induced asthma has been recognized as a disease that
results from chronic airway inﬂammation characteristically
associated with the inﬁltration of lymphocytes, eosinophils,
and neutrophils into the bronchial lumen [3,4]. In our experi-
ment, we demonstrate that OVA-induced asthma increased
levels of eosinophil inﬁlteration, eosinophils peroxidase activ-
ity, eotaxin, and the thicknesses of bronchial wall and area
of smooth muscle. But they were signiﬁcantly decreased by
administration of D-pinitol.
It was recently demonstrated that the administration of an
MMP inhibitor reduces the migration of inﬂammatory cells
through the endothelial and epithelial basement membranes
[27]. Additionally, an MMP inhibitor regulates inﬂammatory
cell migration by reducing ICAM-1 and VCAM-1 expression
in a murine model of toluene diisocyanate-induced asthma
[28]. In our murine model of asthma, intraperitoneally inject-
edmice with 10 mg/kg/day, 20 mg/kg/day D-pinitol to evaluate
the eﬀect of D-pinitol on the expression of MMP-9, T-bet and
GATA3 mRNA. In this study, D-pinitol reduced levels of
MMP-9, GATA3 in lung tissues of D-pinitol treated mice.
Conversely, D-pinitol treatment resulted in increase in Th1
transcription factor T-bet.
T-bet, a member of the T-box family of transcription fac-
tors, is a master determinant of Th1 lineage [28,29]. Indeed,
T-bet deﬁcient mice exhibit a profound lack of Th1 immune re-
sponses [30] and ectopic expression of T-bet in murine Th2
cells directs activation of IFN-c, as well as the upregulation
of IL-12Rb [31,32]. Th1 cytokines are known to inhibit allergic
responses [33,34]. GATA-3 belongs to the GATA family of
Fig. 8. D-pinitol increase the secretion of IFN-c and decrease levels of
IL-4 in OVA-induced BALB/c spleen cell. Spleen cells were stimulated
by 2lg/ml OVA-peptide (OVA 323–339) for 24 h. P10, 20 indicates D-
pinitol 10 lg/ml, 20 lg/ml pre-treated 2 h before OVA-peptide.
Fig. 9. Eﬀect of D-pinitol on airway responsiveness in OVA-sensitized
and OVA-challenged mice. Airway responsiveness was measured at
24 h after the last challenge in saline-inhaled mice administered PBS
(PBS), OVA-sensitized mice administered saline (OVA) and OVA-
sensitized mice administered D-pinitol (OVA + Pin 10 mg/kg/day,
20 mg/kg/day). Airway responsiveness to aerosolized methacholine
was measured in unrestrained, conscious mice. Mice were placed into
the main chamber and were nebulized ﬁrst with PBS, then with
increasing doses (2.5–50 mg/ml) of methacholine for 3 min for each
nebulization. Readings of breathing parameters were taken for 3 min
after each nebulization during which Penh values were determined.
Data represent means ± S.E.M. from ﬁve independent experiments.
***P < 0.001, **P < 0.01, *P < 0.05.
Fig. 10. The eﬀect of D-pinitol on MMP-9 production in lung tissues
of OVA-sensitized and OVA-challenged. Sampling was performed at
48 h after challenge with the PBS (Con), OVA (OVA), or OVA plus D-
pinitol 10 mg/kg/day (OVA + Pin 10) and analyzed by zymography.
All of the groups of the experiment showed MMP-9 production, but
the OVA plus D-pinitol group only showed the active form of MMP-9.
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this family have been identiﬁed in avians, with homologues
in mammals and avians. Based on their expression proﬁle
and structure, the GATA proteins may be classiﬁed as haema-
topoietic (GATA-1 to GATA-3) [35] or non-haematopoietic
(GATA-4 to GATA-6). Naive CD4+ T cells express low levels
of GATA-3 mRNA18. The expression of GATA-3 is, how-
ever, markedly upregulated in cells diﬀerentiating along the
Th2 lineage, and is downregulated in cells diﬀerentiating along
the Th1 pathway [36].
Our data demonstrate that D-pinitol reduces the increased
levels of GATA3 mRNA in OVA-sensitized and -challenged
mice (Fig. 4). Also, it suggest that D-pinitol treatment is a
novel, selective way to simultaneously suppress GATA-3 and
increase T-bet expression in asthmatic reactions in vivo [24].
Also, we examined Th1/Th2 cytokine production in CD4+ T
cell. D-pinitol reduces the increased levels of IL-4, Th2 cyto-
kine production in OVA-sensitized and -challenged mice.
The other side, it increases IFN-c, Th1 cytokine production
in D-pinitol administrated mice. Taken together these suggest
that T-bet, GATA-3 might be a candidate gene for asthma,
and a regulator of Th1/Th2 balance.
In conclusion, our results strongly indicate that D-pinitol re-
duces allergic airway inﬂammation and hyperresponsiveness
due to the alteration of Th1/Th2 polarization via the suppres-
sion of GATA-3 and increase of T-bet expression. Therefore,
our data suggest that D-pinitol might oﬀer a new therapeutic
approach to allergic airway diseases.
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